BeTaL-GBI: Admission-Aware Benchmark Tuning and Full-Stack Verification of Geometric Belief Interfaces
Organizations: Light Imaging Technologies, Inc.
Abstract
A verification substrate is more credible when exposing errors in its own claims, not just model outputs. GBI-DCSE v3 falsified an architectural claim: the reported Fisher value epsilon ~ 0.066 satisfies the kappa^2 <= 10^4 budget only on the slice [epsilon, 3, 4, 5], while the full box [epsilon, 20]^4 requires epsilon ~ 0.326472. This erratum highlights whether an enterprise verification architecture can isolate interface failure, task competence, policy admissibility, and control integrity while keeping claims auditable. BoundaryBench v0.1 established the baseline: Qwen3-4B-Instruct-2507 completed 768 frozen executions, but 0% cleared the contract (369 failed parsing, 399 failed validation), limiting downstream selectivity metrics. This companion study evaluates three successive improvements. First, BeTaL-GBI v0.2 applies Benchmark Tuning with an LLM-in-the-loop over 2,218,750,380 grid points, separating format admission from conditional performance (rho_adm = N_admitted/N; rho_task = N_verified/N_admitted). Following schema repair, a model-free feedback search achieves a 2.87% mean held-out target gap, outperforming non-feedback baselines (13.61%, 11.46%). Second, GBI v2 swaps static keys for a reference-independent witness state W and policy P. Across 512 synthetic tasks, a 16-gate policy detects all 116 injected severe contradictions and accepts all 99 clean records (broad denominator: 4.27%). Hallucinator and evidence-forger surrogates are blocked with zero silent promotions. Third, GBI-DCSE v3 maps 99 claims to machine-readable evidence: 95 of 96 testable claims pass, with 148 standalone checks executed without failure. The harness exercises signed ledgers, PBFT quorums, and enclave forgery across 62 configurations. Under synthetic conditions, GBI-DCSE is a selective, policy-versioned, self-auditing test and routing substrate.
Figures & tables
| Synthetic proposal | Authoritative context | Example policy action | What GBI does not decide |
|---|---|---|---|
| Amoxicillin medication request with a record of serious penicillin/beta-lactam hypersensitivity | FHIR AllergyIntolerance is designed to represent patient-specific risk from substance exposure and can inform clinical decision support; current U.S. AMOXIL labeling lists a history of serious hypersensitivity to amoxicillin or other beta-lactams as a contraindication [ 12 , 13 ] . | A version-pinned local policy could refuse autonomous commit and require named clinical review or an authorized override with provenance. | It does not diagnose an allergy, select an alternative antibiotic, or determine patient-specific treatment. |
| Metformin medication request with required renal-function evidence absent or stale | Current DailyMed labeling directs renal-function assessment before initiation and periodically thereafter, with explicit eGFR-related restrictions [ 14 ] . | If the institution’s declared requires qualifying renal context, missing evidence can route the proposed write to abstention, quarantine, or expert review until the required evidence is present. | It does not set an individualized dose, diagnose renal impairment, or independently decide whether metformin is clinically appropriate. |
| Boundary | Evaluated here | Not claimed |
|---|---|---|
| Model behavior | Frozen v0.1 Qwen outputs are a historical empirical baseline; v0.2–v3 evaluate benchmark and verification machinery. | General hallucination containment, frontier-model capability, or new LLM performance in v0.2–v3. |
| Clinical authority | Synthetic witness/policy states route proposed EHR actions and expose the reason for refusal/review. | Diagnosis, treatment recommendation, autonomous prescribing, clinical safety, medical-device validation, or replacement of clinician judgment. |
| Policy authority | Deterministic execution, version binding, ablations, replay, and reference independence of the declared . | That an institution’s policy is clinically, legally, or ethically correct; a verifier can faithfully execute a bad policy. |
| Infrastructure | Software models/proxies exercise signatures, attestation checks, quorum arithmetic, certificates, rollback, receipts, and FHIR-like transaction semantics. | Live TEE attestation, a running BFT cluster, production FHIR integration, hardware-root security, or a zero-knowledge proof system. |
| Mathematical diagnostics | Finite Boolean, Fisher, mapping-cone, and certificate properties under declared numerical tests. | Clinical truth from geometry; mapping-cone diagnostics have zero scoring weight. |
| Portability | Code-level reuse is measured in a second synthetic sensitive-infrastructure instantiation. | Readiness for real healthcare, finance, government, or classified infrastructure without domain-specific authority and validation. |
| Parameter | Min | Max | Step/count | Operational interpretation |
|---|---|---|---|---|
| patient identity normalization | 0 | 1 | 0.05 | identity ambiguity/noise |
| orphan rate | 0 | 0.5 | 0.05 | orphan/duplicate burden |
| field anomaly bleed | 0 | 0.5 | 0.05 | structured/free-text contamination |
| code-system version validation | 0 | 1 | 0.05 | terminology/version difficulty |
| mapping arity | 1 | 6 | 6 values | RPMS-to-FHIR mapping branching |
| temporal ambiguity | 0 | 1 | 0.05 | active/historical ambiguity |
| Strategy | Mean search gap | Mean held-out gap | Held-out SD across levels |
|---|---|---|---|
| Feedback coordinate | 5.23% | 2.87% | 2.30 pp |
| Random sampling + PPR | 20.90% | 13.61% | 8.68 pp |
| Best-of-N | 23.72% | 11.46% | 17.19 pp |
| Level | Target | Feedback | Random+PPR | Best-of-N |
|---|---|---|---|---|
| Hard | 0.25 | 0.78% | 6.25% | 0.39% |
| Medium | 0.50 | 1.17% | 6.64% | 0.00% |
| Easy | 0.75 | 3.91% | 17.58% | 8.98% |
| Trivial | 0.90 | 5.63% | 23.98% | 36.48% |
| Target tier | Range | 0.25 | 0.50 | 0.75 | 0.90 |
|---|---|---|---|---|---|
| Low (c=0.35) | 0.016–0.727 | reachable | reachable | floor 2.34% | floor 17.34% |
| Mid (c=0.55) | 0.121–0.898 | reachable | reachable | reachable | floor 0.16% |
| High (c=0.75) | 0.238–0.941 | reachable | reachable | reachable | reachable |
| Quantity | Frozen floor | After repair |
|---|---|---|
| Admissibility rate | 0.0000 | 0.4648 |
| Coverage | 0.0000 | 0.4473 |
| Selective risk | undefined | 1.0 (defined) |
| Verified completion | 0.0000 | 0.0000 |
| Class | Count | Class | Count |
| Identity ambiguous | 12 | Identity unresolvable | 12 |
| Provenance absent | 11 | Required evidence absent | 11 |
| Structured field fully contaminated | 11 | Terminology unpinned | 12 |
| Terminology unsigned | 12 | Terminology unresolvable | 11 |
| Validity expired | 12 | Validity invalid | 12 |
| Total | 116 | ||
| Adversary | Attack | Admitted | Silent promotions |
|---|---|---|---|
| Confident hallucinator | Emits format-valid content, confidence 0.97, correct evidence references, and always requests admission. It makes 221 attempted over-admissions. | 98 | 0 |
| Evidence forger | Proposes the witness-consistent action but cites one nonexistent evidence reference and an unwitnessed source record. | 0/512 | 0 |
| Group | Measure | Result | Evidence class |
|---|---|---|---|
| Mathematical | Spectral gap on genuine cone Laplacians | 1.0000 (within floating point) | MEASURED |
| Mathematical | Fisher condition number over corrected evidence box | 9998.3472 | MEASURED |
| Systems | End-to-end enclave latency ms | 0.0968 ms CPU-only software path | PARTIAL PROXY |
| Quarantine scope | Admissible work surviving | Liveness |
|---|---|---|
| Record-scoped refusals only | 112/112 | 1.000 |
| Declared scope incl. mandated shared freezes | 84/112 | 0.750 |
| Naive closure over every shared reference | 84/112 | 0.750 |
| Coarse family-level closure | 0/112 | 0.000 |
| Ceiling | Box-wide | One-dimensional slice value |
|---|---|---|
| 5 | 0.093001 | 0.066022 |
| 10 | 0.161794 | 0.066022 |
| 20 | 0.326472 | 0.066022 |
| 50 | 0.918946 | 0.066022 |
| Quantity | Count |
|---|---|
| Total registered claims | 99 |
| Testable claims | 96 |
| Testable claims met | 95 |
| Testable claims unmet | 1 (erratum) |
| Explicitly out of scope | 3 |
| Declared verification checks | 148 |
| Resource | Sparse path | Dense path | Declared budget |
|---|---|---|---|
| Floating-point operations | 8,440 | 124,416,000 | 5,000,000 |
| Heap bytes | 13,440 | 921,600 | 262,144 |
| Syscalls | 2 | not the enclave path | 64 |
| Measure | Result |
|---|---|
| Severe contradiction sensitivity | 265/265 = 1.000 |
| Severe contradictions missed | 0 |
| False conflicts over fully clean records | 0/175 = 0.000 |
| Receipt chain | valid |
| Ledger | valid and non-equivocating |
| Forced-bad-entry atomicity | held |
| Stage | Main question | Positive evidence | What it does not establish |
|---|---|---|---|
| v0.1 | Will a frozen model output cross a strict contract? | 768 executions all fail closed at parse/schema. | Selective utility, task difficulty, policy quality, general model safety. |
| v0.2 | Can benchmark difficulty be tuned without confusing interface failure with task failure? | Degenerate objective detected at zero admission; after repair, feedback search reaches 2.87% mean held-out target gap. | LLM-designer performance, commercial-model difficulty, full-space optimality. |
| v2 | Can the GBI gate selectively admit clean work and refuse declared severe contradictions without answer-key leakage? | 116/116 severe injections caught; 0/99 narrow clean false conflicts; zero silent promotions under two synthetic adversaries; policy ablations fail. | Real clinical safety, complete taxonomy, adversarial robustness to arbitrary attacks. |
| v3 | Do the broader testable manuscript claims have executable evidence? | 95/96 testable claim criteria met; 148 declared checks; systems modules, receipts, rollback and portability exercised. | Real TEE/BFT/FHIR/ZK deployment, real data, operational accreditation. |
Appendix figures & tables1 asset
Supplementary material from the paper’s appendix.
Appendix
| Claim | Why out of scope | What is established instead |
| C-9.16 | No zero-knowledge proof system is present. | Finite certificate predicate, public-input binding, and a blinded binding commitment. |
| C-B1.7 | Retrospective clinical playback requires a preregistered cohort and expert adjudication. | Receipt-driven replay reproduces 14/14 synthetic decisions. |
| C-B2.4 | Attestation bootstrapping target requires real TEE quote generation and an attestation-service handshake. | Software verification path is measured only as a proxy and is not promoted to the hardware target. |